Article
Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma
13 Sept 2013
Abstract excerpt
BACKGROUND: Despite therapeutic advances in targeted therapy, metastatic renal cell carcinoma (RCC) remains incurable for the vast majority of patients. Key molecular events in the pathogenesis of RCC include inactivation of the VHL tumour suppressor gene (TSG), inactivation of chromosome 3p TSGs implicated in chromatin modification and remodelling and de novo tumour-specific promoter methylation of renal TSGs....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
